Literature DB >> 30664706

Pulmonary group 2 innate lymphoid cells: surprises and challenges.

Malcolm R Starkey1, Andrew Nj McKenzie2, Gabrielle T Belz3, Philip M Hansbro4,5.   

Abstract

Group 2 innate lymphoid cells (ILC2s) are a recently described subset of innate lymphocytes with important immune and homeostatic functions at multiple tissue sites, especially the lung. These cells expand locally after birth and during postnatal lung maturation and are present in the lung and other peripheral organs. They are modified by a variety of processes and mediate inflammatory responses to respiratory pathogens, inhaled allergens and noxious particles. Here, we review the emerging roles of ILC2s in pulmonary homeostasis and discuss recent and surprising advances in our understanding of how hormones, age, neurotransmitters, environmental challenges, and infection influence ILC2s. We also review how these responses may underpin the development, progression and severity of pulmonary inflammation and chronic lung diseases and highlight some of the remaining challenges for ILC2 biology.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30664706      PMCID: PMC6436699          DOI: 10.1038/s41385-018-0130-4

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  181 in total

Review 1.  Innate lymphoid cells in secondary lymphoid organs.

Authors:  Yotam E Bar-Ephraïm; Reina E Mebius
Journal:  Immunol Rev       Date:  2016-05       Impact factor: 12.988

Review 2.  Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22.

Authors:  Gregory F Sonnenberg; Lynette A Fouser; David Artis
Journal:  Nat Immunol       Date:  2011-05       Impact factor: 25.606

3.  RORγt+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota.

Authors:  Shinichiro Sawa; Matthias Lochner; Naoko Satoh-Takayama; Sophie Dulauroy; Marion Bérard; Melanie Kleinschek; Daniel Cua; James P Di Santo; Gérard Eberl
Journal:  Nat Immunol       Date:  2011-02-20       Impact factor: 25.606

4.  Activated type 2 innate lymphoid cells regulate beige fat biogenesis.

Authors:  Min-Woo Lee; Justin I Odegaard; Lata Mukundan; Yifu Qiu; Ari B Molofsky; Jesse C Nussbaum; Karen Yun; Richard M Locksley; Ajay Chawla
Journal:  Cell       Date:  2014-12-24       Impact factor: 41.582

Review 5.  Control of epithelial cell function by interleukin-22-producing RORγt+ innate lymphoid cells.

Authors:  Stephanie L Sanos; Cedric Vonarbourg; Arthur Mortha; Andreas Diefenbach
Journal:  Immunology       Date:  2011-04       Impact factor: 7.397

6.  Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity.

Authors:  Daniel R Neill; See Heng Wong; Agustin Bellosi; Robin J Flynn; Maria Daly; Theresa K A Langford; Christine Bucks; Colleen M Kane; Padraic G Fallon; Richard Pannell; Helen E Jolin; Andrew N J McKenzie
Journal:  Nature       Date:  2010-03-03       Impact factor: 49.962

7.  Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus.

Authors:  Laurel A Monticelli; Gregory F Sonnenberg; Michael C Abt; Theresa Alenghat; Carly G K Ziegler; Travis A Doering; Jill M Angelosanto; Brian J Laidlaw; Cliff Y Yang; Taheri Sathaliyawala; Masaru Kubota; Damian Turner; Joshua M Diamond; Ananda W Goldrath; Donna L Farber; Ronald G Collman; E John Wherry; David Artis
Journal:  Nat Immunol       Date:  2011-11       Impact factor: 25.606

8.  Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation.

Authors:  Timotheus Y F Halim; Catherine A Steer; Laura Mathä; Matthew J Gold; Itziar Martinez-Gonzalez; Kelly M McNagny; Andrew N J McKenzie; Fumio Takei
Journal:  Immunity       Date:  2014-03-06       Impact factor: 31.745

Review 9.  Innate lymphoid cells--a proposal for uniform nomenclature.

Authors:  Hergen Spits; David Artis; Marco Colonna; Andreas Diefenbach; James P Di Santo; Gerard Eberl; Shigeo Koyasu; Richard M Locksley; Andrew N J McKenzie; Reina E Mebius; Fiona Powrie; Eric Vivier
Journal:  Nat Rev Immunol       Date:  2013-02       Impact factor: 53.106

10.  Epidermal Notch1 recruits RORγ(+) group 3 innate lymphoid cells to orchestrate normal skin repair.

Authors:  Zhi Li; Tom Hodgkinson; Elizabeth J Gothard; Soulmaz Boroumand; Rebecca Lamb; Ian Cummins; Priyanka Narang; Amy Sawtell; Jenny Coles; German Leonov; Andrea Reboldi; Christopher D Buckley; Tom Cupedo; Christian Siebel; Ardeshir Bayat; Mark C Coles; Carrie A Ambler
Journal:  Nat Commun       Date:  2016-04-21       Impact factor: 14.919

View more
  19 in total

1.  Adenosine restrains ILC2-driven allergic airway inflammation via A2A receptor.

Authors:  Qiang Xiao; Xu Han; Gaoyu Liu; Dongmei Zhou; Lijuan Zhang; Juan He; Haixu Xu; Pan Zhou; Quan Yang; Jiangfan Chen; Jie Zhou; Guanmin Jiang; Zhi Yao
Journal:  Mucosal Immunol       Date:  2021-12-17       Impact factor: 7.313

Review 2.  Obesity, Inflammation, and Immune System in Osteoarthritis.

Authors:  Udhaya Nedunchezhiyan; Ibin Varughese; Antonia RuJia Sun; Xiaoxin Wu; Ross Crawford; Indira Prasadam
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

Review 3.  Immune Repertoire and Advancements in Nanotherapeutics for the Impediment of Severe Steroid Resistant Asthma (SSR).

Authors:  Narasimha M Beeraka; Runze Zhou; Xiaoyan Wang; Hemanth Vikram P R; Tegginamath Pramod Kumar; Junqi Liu; M V Greeshma; Subhankar P Mandal; B M Gurupadayya; Ruitai Fan
Journal:  Int J Nanomedicine       Date:  2022-05-12

Review 4.  Emerging concepts and directed therapeutics for the management of asthma: regulating the regulators.

Authors:  Madhur D Shastri; Wai Chin Chong; Kamal Dua; Gregory M Peterson; Rahul P Patel; Malik Q Mahmood; Murtaza Tambuwala; Dinesh K Chellappan; Nicole G Hansbro; Shakti D Shukla; Philip M Hansbro
Journal:  Inflammopharmacology       Date:  2020-11-05       Impact factor: 4.473

5.  Airway administration of OM-85, a bacterial lysate, blocks experimental asthma by targeting dendritic cells and the epithelium/IL-33/ILC2 axis.

Authors:  Vadim Pivniouk; Joao A Gimenes-Junior; Peace Ezeh; Ashley Michael; Oksana Pivniouk; Seongmin Hahn; Sydney R VanLinden; Sean P Malone; Amir Abidov; Dayna Anderson; Justyna Gozdz; Avery DeVries; Fernando D Martinez; Christian Pasquali; Donata Vercelli
Journal:  J Allergy Clin Immunol       Date:  2021-09-22       Impact factor: 10.793

6.  ILC2 Lung-Homing in Cystic Fibrosis Patients: Functional Involvement of CCR6 and Impact on Respiratory Failure.

Authors:  Anja Schulz-Kuhnt; Vicky Greif; Kai Hildner; Lisa Knipfer; Michael Döbrönti; Sabine Zirlik; Florian Fuchs; Raja Atreya; Sebastian Zundler; Rocío López-Posadas; Clemens Neufert; Andreas Ramming; Alexander Kiefer; Anika Grüneboom; Erwin Strasser; Stefan Wirtz; Markus F Neurath; Imke Atreya
Journal:  Front Immunol       Date:  2020-05-07       Impact factor: 7.561

7.  Quantification and role of innate lymphoid cell subsets in Chronic Obstructive Pulmonary Disease.

Authors:  Evy E Blomme; Sharen Provoost; Elise G De Smet; Katrien C De Grove; Hannelore P Van Eeckhoutte; Joyceline De Volder; Philip M Hansbro; Matteo Bonato; Marina Saetta; Sara Ra Wijnant; Fien Verhamme; Guy F Joos; Ken R Bracke; Guy G Brusselle; Tania Maes
Journal:  Clin Transl Immunology       Date:  2021-06-05

8.  House Dust Mite Induces Bone Marrow IL-33-Responsive ILC2s and TH Cells.

Authors:  Emma Boberg; Kristina Johansson; Carina Malmhäll; Julie Weidner; Madeleine Rådinger
Journal:  Int J Mol Sci       Date:  2020-05-26       Impact factor: 5.923

Review 9.  Group 2 Innate Lymphoid Cells Are Redundant in Experimental Renal Ischemia-Reperfusion Injury.

Authors:  Guy J M Cameron; Kelly M Cautivo; Svenja Loering; Simon H Jiang; Aniruddh V Deshpande; Paul S Foster; Andrew N J McKenzie; Ari B Molofsky; Philip M Hansbro; Malcolm R Starkey
Journal:  Front Immunol       Date:  2019-04-16       Impact factor: 7.561

Review 10.  The perplexing role of RAGE in pulmonary fibrosis: causality or casualty?

Authors:  Timothy N Perkins; Tim D Oury
Journal:  Ther Adv Respir Dis       Date:  2021 Jan-Dec       Impact factor: 4.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.